For more than 25 years, PET/CT technology has been at the forefront of nuclear medicine, helping clinicians detect disease early, personalize treatment, and improve outcomes for patients across the globe. From engineers motivated by their upbringing in Colombia to researchers advancing whole-body dynamic imaging, the evolution of PET/CT is a testament to continuous innovation and a shared commitment to better care.
PET/CT is a powerful imaging modality that combines the functional insights of Positron Emission Tomography (PET) with the anatomical detail of Computed Tomography (CT), enabling clinicians to detect disease early and more accurately. It plays a critical role across multiple care pathways—including oncology, cardiology, and neurology—by helping guide diagnosis, treatment planning, and therapy monitoring. Whether assessing tumor metabolism, evaluating cardiac perfusion, or identifying neurological disorders, PET/CT supports more confident clinical decisions to enable better patient outcomes.
Explore how GE HealthCare is driving progress in nuclear medicine and shaping the next chapter of precision care.
Close to Home: How One Engineer Dedicates His Life to Bringing Better Imaging Technology to Colombia
Jorge Uribe’s journey from a small Colombian town to leading innovations in medical imaging at GE HealthCare is deeply rooted in personal loss and a strong sense of purpose. Growing up in Manizales, Jorge’s early love for physics eventually led him to a PhD in experimental particle physics. But it was the tragic loss of his father to undiagnosed colon cancer and his mother-in-law to liver cancer that transformed his career into a mission. These experiences revealed the devastating consequences of limited access to advanced imaging technologies in underserved regions, fueling his hope to make PET/CT scanners more accessible and affordable.
At GE Healthcare, Jorge has played a pivotal role in developing systems like the Discovery IQ, Discovery MI, and its newest Omni Legend PET/CT, which have enabled improved diagnostic capabilities for hundreds of thousands of patients worldwide. His work is not just technical — it’s deeply personal. When he learned that his hometown hospital was fundraising for its first PET/CT system, it was a full-circle moment that affirmed the impact of his life’s work. Jorge’s story is a moving example of how personal conviction can lead to global change, bringing life-saving technology closer to communities that need it most.
Read the full story here.
Transforming Healthcare: How Precision Care and Advanced Technology are Helping Enhance Lives
In the heart of GE HealthCare’s mission lies a deeply human commitment: to place patients at the center of every innovation. This comes to life through the stories of Ella, Doug, and Ashmeet—three individuals whose courage and resilience are matched by the transformative power of precision care. Ella, a vibrant woman diagnosed with pancreatic cancer 14 years ago, continues to live to the fullest, running a tamale business, traveling, and spending time with family. Her recent therapy, aided by advanced imaging, has shown promising results. Doug, battling metastatic prostate cancer, finds hope and strength in Theranostics treatment, which he calls a “life extender.” His love for his family fuels his fight.
Ashmeet’s experience offers a raw and emotional glimpse into the patient experience. At just 24, she faced Hodgkin’s lymphoma, while managing claustrophobia during her PET/CT scans. Her second scan, performed with Canada’s first Omni Legend PET/CT, was faster, more comfortable, and revealed her chemotherapy had worked. Beyond her own health battle, Ashmeet dedicates her life to caring for children with special needs, embodying compassion and resilience.
These stories reflect how GE HealthCare’s bold advancements in precision care—like faster, more accurate imaging and personalized treatment pathways—are not only changing healthcare; they’re helping change lives. They remind us that behind every scan, every diagnosis, and every innovation, there is a person with dreams, loved ones, and a future worth fighting for.
Read the full story here.
25 years of PET/CT: A legacy of innovation, a future of possibility
For 25 years, GE HealthCare has been at the forefront of PET/CT innovation, transforming how diseases are detected, diagnosed, and monitored. What began as a bold vision in the early 1990s—when PET was still largely a research tool—has evolved into a legacy of clinical impact. From the launch of the first commercially available PET/CT system in 2001 to today’s mobile and AI-enhanced platforms, this journey has been powered by the ingenuity and dedication of GE HealthCare’s people. Engineers, scientists, and clinical partners across the globe have worked tirelessly to push boundaries, turning complex challenges into life-changing solutions for patients everywhere.
This legacy is more than technological—it’s deeply human. Every advancement in PET/CT has been shaped by teams who believed in the power of innovation to improve lives. Whether developing mobile units to reach remote communities or refining image quality to detect disease earlier and more accurately, their work reflects a shared commitment to expanding access and elevating care. As GE HealthCare looks to the future, that same spirit of possibility continues to guide its mission: enabling providers with the tools they need to deliver precise, compassionate care—wherever and whenever it’s needed most.
Read the full story here.
_______________________________________________________
Over the past 25 years, the expansion of PET/CT technology has reshaped the landscape of nuclear medicine, driving early disease detection, more personalized treatment planning, and improved patient outcomes across the globe. Innovations in image quality, sensitivity, and radiopharmaceuticals have empowered clinicians to diagnose with greater accuracy and confidence, even in complex cases. As access to these technologies grows—from major medical centers to underserved regions—GE HealthCare’s commitment to precision care is helping build a future where healthcare has no limits, and every patient has the opportunity to benefit from personalized medicine.
Learn more about GE HealthCare’s PET/CT portfolio here, or visit us at EANM 2025.
